Search results for “Kinase inhibition” companies
Free sign up to view the full data
Key Players
Order by:
Innovation Intensity
With the analysis among 16,419 patents, we discovered top 460 key players by total patent application. Novartis AG, Vertex Pharmaceuticals, Inc., Bristol Myers Squibb Co. are dominant in this area. They take 12.50% of the total patent filing.
Basel-Stadt, Switzerland
Patent: 894
Massachusetts, United States
Patent: 642
New York, United States
Patent: 516
Colorado, United States
Patent: 461
Switzerland
Patent: 458
Delaware, United States
Patent: 259
California, United States
Patent: 256
California, United States
Patent: 253
Hessen, Germany
Patent: 238
New York, United States
Patent: 234
Startups & Unicorns
Order by:
Innovation Intensity
With the analysis among 335 patents, we discovered top 44 start-ups by total patent application. Institut National de la Santé et de la Recherche Médicale, Woolsey Pharmaceuticals, Inc., iOmx Therapeutics AG are active in this area.
STARTUP
France
Patent: 45
STARTUP
New York, United States
Patent: 38
STARTUP
Bayern, Germany
Patent: 27
STARTUP
South Korea
Patent: 20
STARTUP
Utah, United States
Patent: 20
STARTUP
United States
Patent: 17
STARTUP
California, United States
Patent: 16
STARTUP
Guangdong Sheng, China
Patent: 15
STARTUP
California, United States
Patent: 14
STARTUP
Massachusetts, United States
Patent: 13
Fast-Growing
Order by:
Innovation in recent 5 years
With the analysis among related 5,157 patents applied in the last 5 years. We discover 500 most active companies in this area. The fast-growing Rigel Pharmaceuticals, Inc., Array BioPharma, Inc., Theravance Biopharma R&D IP LLC take 9.23% of patent filing during this period.
California, United States
Patent: 177
Colorado, United States
Patent: 151
California, United States
Patent: 148
The Board of Regents of The University of Texas System
Texas, United States
Patent: 119
South Korea
Patent: 106
Switzerland
Patent: 84
Delaware, United States
Patent: 80
New York, United States
Patent: 76
Jiangsu Sheng, China
Patent: 75
Emilia-Romagna, Italy
Patent: 56
New Entrants
Order by:
Innovation in recent 5 years
With the analysis among related 5,157 patents in last 5 years, we discover 263 new entrants. Zhejiang Tongkang Medicine Co Ltd, Shanghai Hansoh Biomedical Co. Ltd., Nanjing Mingde New Drug Research and Development Co., Ltd. are the most active new entrants in this area.
Zhejiang Sheng, China
Patent: 53
Shanghai Shi, China
Patent: 43
Jiangsu Sheng, China
Patent: 42
Shanghai Shi, China
Patent: 38
STARTUP
New York, United States
Patent: 38
Massachusetts, United States
Patent: 34
California, United States
Patent: 33
Massachusetts, United States
Patent: 29
Beijing Shi, China
Patent: 28
New York, United States
Patent: 27
Research Institutions
Order by:
Innovation Intensity
With the analysis among 1,742 patents, we discovered top 227 universities and scientific research institutions by total patent application. Shanghai Institute of Materia Medica Chinese Academy of Sciences, Icahn School of Medicine at Mount Sinai, The Scripps Research Institute are dominant in this area. They take 18.37% of the total patent filing.
Shanghai Shi, China
Patent: 60
New York, United States
Patent: 51
California, United States
Patent: 34
South Korea
Patent: 30
Anhui Sheng, China
Patent: 29
Georgia, United States
Patent: 25
Colorado, United States
Patent: 24
Vlaams-Brabant, Belgium
Patent: 23
Kyoto-fu, Japan
Patent: 22
Jiangsu Sheng, China
Patent: 22
Keywords Quick Entry
Popular
Physics
Chemistry
Engineering
Materials science
Computer science
Biology
Medicine
MetalElectrodeVoltageSemiconductorPolymerElectricityCoatingFiberDisplay deviceRaw materialElectric motorUltimate tensile strengthNozzleCarbonBuilding constructionAlkylService lifeElectronOxideOxygenSolventControl unitFlangeControl systemDrugLight sourcePistonDiseaseElectric powerHigh pressure
View more
Page generation time: